SEC Form 4 · accession 0001140361-17-019046
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Meier
Director
Period of report
May 5, 2017
Accepted (ET)
May 9, 2017 · 1:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 5, 2017 | M | 7,500 | $17.33 | A | 34,260 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1 | $17.33 | May 5, 2017 | M | 7,500 | D | Dec 7, 2007 | Jun 6, 2017 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1Reflects the number of stock options outstanding after the transaction from this specific stock option grant.